癌症治疗的起源。
Origins of cancer therapy.
作者信息
Papac R J
机构信息
Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
出版信息
Yale J Biol Med. 2001 Nov-Dec;74(6):391-8.
Abstract
This is a brief overview of the development of cancer therapy with a focus on systemic therapy. The modern era of chemotherapy developed at Yale University Medical School during World War II, a fact that has been generally unrecognized until recently. The observations preceding and involved in the discovery of effective drugs for cancer seem particularly pertinent for this anniversary year.
摘要
这是一篇关于癌症治疗发展的简要概述，重点是全身治疗。化疗的现代时代是在第二次世界大战期间于耶鲁大学医学院发展起来的，这一事实直到最近才被普遍认识到。在发现癌症有效药物之前及过程中的观察结果，在这个周年纪念年似乎尤为相关。
相似文献
1
Origins of cancer therapy.
Yale J Biol Med. 2001 Nov-Dec;74(6):391-8.
2
Cancer chemotherapy: an annotated history.
J Vet Intern Med. 2010 Nov-Dec;24(6):1249-62. doi: 10.1111/j.1939-1676.2010.0590.x. Epub 2010 Sep 14.
3
2000 years of chemotherapy of tumors.
Cancer. 2005 Mar 15;103(6):1097-102. doi: 10.1002/cncr.20908.
4
Two hundred years of cancer research.
N Engl J Med. 2012 Jun 7;366(23):2207-14. doi: 10.1056/NEJMra1204479. Epub 2012 May 30.
5
An anniversary for cancer chemotherapy.
JAMA. 2006 Sep 27;296(12):1518-20. doi: 10.1001/jama.296.12.1518.
6
Therapy and disease concepts: the history (and future?) of antimony in cancer.
J Hist Med Allied Sci. 2002 Jan;57(1):61-78. doi: 10.1093/jhmas/57.1.61.
7
[The history of cancer therapy].
Gesnerus. 1980;37(3-4):189-97.
8
Ancient and medieval chemotherapy for cancer.
Isis. 1985 Sep;76(283):319-30. doi: 10.1086/353876.
9
The historical development of cancer chemotherapy.
Semin Oncol. 1977 Jun;4(2):135-46.
10
[History of cancer and chemotherapy before chemotherapy].
Hist Sci Med. 2014 Oct-Dec;48(4):469-74.
引用本文的文献
1
The Persistent Power of the Taxane/Platin Chemotherapy.
Cancers (Basel). 2025 Apr 2;17(7):1208. doi: 10.3390/cancers17071208.
2
History of Leukemia, Revisited.
Curr Oncol Rep. 2025 Apr;27(4):472-482. doi: 10.1007/s11912-025-01658-2. Epub 2025 Mar 19.
3
Advancements and challenges in brain cancer therapeutics.
Exploration (Beijing). 2024 May 16;4(6):20230177. doi: 10.1002/EXP.20230177. eCollection 2024 Dec.
4
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.
Genes Dis. 2022 Mar 18;10(4):1367-1401. doi: 10.1016/j.gendis.2022.02.007. eCollection 2023 Jul.
5
Learn from antibody-drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy.
Exp Hematol Oncol. 2022 Nov 8;11(1):93. doi: 10.1186/s40164-022-00347-1.
6
A technical note on emerging combination approach involved in the onconanotherapeutics.
Drug Deliv. 2022 Dec;29(1):3197-3212. doi: 10.1080/10717544.2022.2132018.
7
Design, synthesis and computational study of new benzofuran hybrids as dual PI3K/VEGFR2 inhibitors targeting cancer.
Sci Rep. 2022 Oct 12;12(1):17104. doi: 10.1038/s41598-022-21277-2.
8
Improved Delivery Performance of n-Butylidenephthalide-Polyethylene Glycol-Gold Nanoparticles Efficient for Enhanced Anti-Cancer Activity in Brain Tumor.
Cells. 2022 Jul 11;11(14):2172. doi: 10.3390/cells11142172.
9
Evolution of Medical Approaches and Prominent Therapies in Breast Cancer.
Cancers (Basel). 2022 May 16;14(10):2450. doi: 10.3390/cancers14102450.
10
Avicenna's Concepts on Cancer Metastasis from the 11 Century.
Galen Med J. 2019 Jan 1;8:e1292. doi: 10.31661/gmj.v8i0.1292. eCollection 2019.
本文引用的文献
1
The Blood and Bone Marrow in Yelloe Cross Gas (Mustard Gas) Poisoning: Changes produced in the Bone Marrow of Fatal Cases.
J Med Res. 1919 Sep;40(3):497-508.3.
2
EXPERIMENTAL AND CLINICAL STUDIES ON THE TREATMENT OF CANCER BY DICHLORETHYLSULPHIDE (MUSTARD GAS.
Ann Surg. 1931 Jan;93(1):190-9. doi: 10.1097/00000658-193101000-00026.
3
The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides.
Science. 1946 Apr 5;103(2675):409-36. doi: 10.1126/science.103.2675.409.
4
The Establishment of the C(3)H Inbred Strain of Mice for the Study of Spontaneous Carcinoma of the Mammary Gland.
Genetics. 1935 Nov;20(6):586-91. doi: 10.1093/genetics/20.6.586.
5
The initial clinical trial of nitrogen mustard.
Am J Surg. 1963 May;105:574-8. doi: 10.1016/0002-9610(63)90232-0.
6
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
N Engl J Med. 2001 Apr 5;344(14):1031-7. doi: 10.1056/NEJM200104053441401.
7
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.
J Clin Oncol. 1999 Jan;17(1):268-76. doi: 10.1200/JCO.1999.17.1.268.
8
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
N Engl J Med. 1998 Nov 5;339(19):1341-8. doi: 10.1056/NEJM199811053391901.
9
10
[The contraceptive pill and vascular accidents].
Harefuah. 1983 Feb 1;104(3):107-8.
Zotero 插件